Rx only · Tablet, Delayed Release · Oral

Naproxen

9 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US14 NDCs
9 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

RxCUI (US)7258

US makers9 labelers

Packages25

DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.954

Latest avg · Jul 22, 2026

+6%

Since Dec 17, 2025

Active US suppliers

44%

Top-2 supplier share*

Labeler	Type	Packages	Status
Proficient Rx LP	unknown	8	SUPPLYING
NuCare Pharmaceuticals, Inc.	unknown	3	SUPPLYING
Aurobindo Pharma Limited	unknown	3	SUPPLYING
Cipla USA Inc.	unknown	3	SUPPLYING
SUNRISE PHARMACEUTICAL, INC	unknown	2	SUPPLYING
ANI Pharmaceuticals, Inc.	unknown	2	SUPPLYING
TRUPHARMA, LLC	unknown	2	SUPPLYING
PD-Rx Pharmaceuticals, Inc.	unknown	1	SUPPLYING
Zameer Pharmaceuticals LLC	unknown	1	SUPPLYING